NovImmune SA – Trademark Portfolio

Entity Type: 03

NovImmune SA holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include GAMIFANT, NOVIMMUNE, and LIGHTCHAIN BIOSCIENCE. The owner is based in Geneva.

15ch. Du Pré Fleuri, Plan les Ouates

Geneva 1228 , CH

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

NovImmune SA's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does NovImmune SA have?

NovImmune SA has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned, 1 cancelled.

What trademark classes does NovImmune SA file in?

NovImmune SA files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are NovImmune SA's most well-known trademarks?

NovImmune SA's registered trademark portfolio includes well-known marks such as GAMIFANT, NOVIMMUNE, and LIGHTCHAIN BIOSCIENCE. These are among 3 currently registered trademarks in the portfolio.

What is NovImmune SA's trademark registration success rate?

NovImmune SA has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.